Io Therapeutics, Inc.
PrivateLast Round
VC Round
Mar 9, 2023
Total Funding Raised
$444,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Io Therapeutics, Inc. is a biopharmaceutical company that discovers and develops retinoid and rexinoid small molecule compounds for the treatment of cancer, neurodegenerative diseases, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Io Therapeutics, Inc. Comparables
Compare Io Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iaterion, Inc. | 86% | |
| Orphagen Pharmaceuticals | 85% | |
| Regen BioPharma Inc | 77% | |
Io Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 9, 2023 | ||||
| Seed | Jan 2, 2014 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 80% MoM, from 1.4K to 2.5K.
- Jul 27, 2026
Monthly visitors increased 41% MoM, reaching 1.4K.
Io Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Io Therapeutics, Inc.'s valuation, stock price, and market status.